Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;19(4):413-23.
doi: 10.1007/s12603-014-0534-0.

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals

Affiliations

Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals

V Berti et al. J Nutr Health Aging. 2015 Apr.

Abstract

Objectives: Epidemiological evidence linking diet, one of the most important modifiable lifestyle factors, and risk of Alzheimer's disease (AD) is rapidly increasing. However, there is little or no evidence for a direct association between dietary nutrients and brain biomarkers of AD. This study identifies nutrient patterns associated with major brain AD biomarkers in a cohort of clinically and cognitively normal (NL) individuals at risk for AD.

Design: Cross-sectional study.

Setting: Manhattan (broader area).

Participants: Fifty-two NL individuals (age 54+12 y, 70% women, Clinical Dementia Rating=0, MMSE>27, neuropsychological test performance within norms by age and education) with complete dietary information and cross-sectional, 3D T1-weighted Magnetic Resonance Imaging (MRI; gray matter volumes, GMV, a marker of brain atrophy), 11C-Pittsburgh compound-B (PiB; a marker of fibrillar amyloid-β, Aβ) and 18F-fluorodeoxyglucose (FDG; a marker of glucose metabolism, METglc) Positron Emission Tomography (PET) scans were examined.

Measurements: Dietary intake of 35 nutrients associated with cognitive function and AD was assessed using the Harvard/Willet Food Frequency Questionnaire. Principal component analysis was used to generate nutrient patterns (NP) from the full nutrient panel. Statistical parametric mapping and voxel based morphometry were used to assess the associations of the identified NPs with AD biomarkers.

Results: None of the participants were diabetics, smokers, or met criteria for obesity. Five NPs were identified: NP1 was characterized by most B-vitamins and several minerals [VitB and Minerals]; NP2 by monounsaturated and polyunsaturated fats, including ω-3 and ω-6 PUFA, and vitamin E [VitE and PUFA]; NP3 by vitamin A, vitamin C, carotenoids and dietary fibers [Anti-oxidants and Fibers]; NP4 by vitamin B12, vitamin D and zinc [VitB12 and D]; NP5 by saturated, trans-saturated fats, cholesterol and sodium [Fats]. Voxel-based analysis showed that NP4 scores [VitB12 and D] were positively associated with METglc and GMV, and negatively associated with PiB retention in AD-vulnerable regions (p<0.001). In addition, both METglc and GMV were positively associated with NP2 scores [VitE and PUFA], and negatively associated with NP5 scores [Fats] (p<0.001), and METglc was positively associated with higher NP3 scores [Anti-oxidants and Fibers] (p<0.001). Adjusting for age, gender, ethnicity, education, caloric intake, BMI, alcohol consumption, family history and Apolipoprotein E (APOE) status did not attenuate these relationships. The identified 'AD-protective' nutrient combination was associated with higher intake of fresh fruit and vegetables, whole grains, fish and low-fat dairies, and lower intake of sweets, fried potatoes, high-fat dairies, processed meat and butter.

Conclusion: Specific dietary NPs are associated with brain biomarkers of AD in NL individuals, suggesting that dietary interventions may play a role in the prevention of AD by modulating AD-risk through its effects on Aβ and associated neuronal impairment.

PubMed Disclaimer

Conflict of interest statement

Competing Interest: Disclosures: Dr. Berti reports no disclosures; Mr. Murray reports no disclosures; Ms. Davies reports no disclosures; Ms. Spector; Dr. Tsui has a patent on a technology that was licensed to Abiant Inc. by NYU and, as such, has a financial interest in this license agreement and hold stock and stock options on the company; Dr. Li has received compensation for consulting services from Abiant Inc; Ms. Williams reports no disclosures; Dr. Pirraglia reports no disclosures; Dr. Vallabhajosula reports no disclosures; Dr. McHugh was PI on an investigator initiated clinical trial supported by Bayer Healthcare Pharmaceuticals; Dr. Pupi reports no disclosures; Dr. de Leon has a patent on a technology that was licensed to Abiant Inc. by NYU and, as such, has a financial interest in this license agreement and hold stock and stock options on the company. Dr. de Leon has received compensation for consulting services from Abiant Inc., has received honoraria from the French Alzheimer Foundation, and was PI on an investigator initiated clinical trial supported by Neuroptix; Dr. Mosconi has a patent on a technology that was licensed to Abiant Inc. by NYU and, as such, has a financial interest in this license agreement and hold stock and stock options on the company. Dr. Mosconi has received compensation for consulting services from Abiant Inc;

Figures

Figure 1
Figure 1. Statistical parametric maps (SPMs) showing associations between nutrient patterns (NPs) and brain glucose metabolism (METglc) on FDG-PET
Brain regions showing positive associations between METglc and (NP2) intake of vitamin E, monounsaturated and polyunsaturated fats (ω-3 and ω-6 PUFA); (NP3) intake vitamin A, vitamin C, carotenoids and dietary fibers; (NP4) intake of vitamin B12, vitamin D and zinc; brain regions showing negative associations between METglc and (NP5) intake of saturated, trans-saturated fats and sodium. SPMs are represented on a color-coded scale at p<0.001, and displayed onto a standardized MRI. Results are adjusted for age, gender, education, BMI, APOE, family history and total caloric intake.
Figure 2
Figure 2. Statistical parametric maps (SPMs) showing significant regional associations between nutrient patterns (NPs), gray matter volumes (GMV) on MRI, and reduced brain amyloid load on PiB-PET
Top panel: brain regions showing positive associations between GMV and (NP4) intake of vitamin B12, vitamin D and zinc; brain regions showing negative associations between GMV and (NP5) intake of saturated, trans-saturated fats and sodium. Bottom panel: brain regions showing negative associations between PiB retention and (NP4) higher intake of vitamin B12, vitamin D and zinc. SPMs are represented on different color-coded scales at p<0.001, and displayed onto a standardized MRI. Results are adjusted for age, gender, education, BMI, APOE, family history and total caloric intake.

References

    1. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–483. - PubMed
    1. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545–1550. - PubMed
    1. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol. 2006;59:912–921. - PMC - PubMed
    1. Scarmeas N, Stern Y, Mayeux R, Manly JJ, Schupf N, Luchsinger JA. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009;66:216–225. - PMC - PubMed
    1. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging. 2003;24:915–919. - PubMed

Publication types

MeSH terms